Nelarabine-induced rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia: a case report

• Main Authors: Akari Utsumi (Author), Yuri Goto (Author), Takaaki Suzuki (Author), Chiaki Imai (Author), Shinichiro Matsui (Author), Emiko Sakaida (Author), Itsuko Ishii (Author)
• Format: Book
• Published: BMC, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Nelarabine is an antineoplastic purine analog used for the treatment of refractory or relapsed T-cell acute lymphoblastic leukemia (T-ALL). The most prominent side effect of nelarabine are neurotoxicity and hematologic disorder, which are considered dose-limiting factors. Althoug...